BackFennec Pharmaceuticals Overview

Fennec Pharmaceuticals Operating Income

Operating Income for FENC.

Quarterly Operating Income

$-119000.00
↓ 85.27% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-6102359.00
↓ 49.07% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin